Assessed degree of alignment between investments made by Corporate Venture Capital affiliates of pharmaceutical companies and the firms’ core strategic interests, as part of a project by TEConomy Partners for PhRM
A titled “Strengthening Biopharmaceutical Innovation: The Growing Role of Corporate Venture Capital.”